148
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Effectiveness of Alpha-toxin Fab Monoclonal Antibody Therapy in Limiting the Pathology of Staphylococcus aureus Keratitis

, , , , , , & show all
Pages 297-303 | Received 11 Dec 2013, Accepted 28 Apr 2014, Published online: 09 Jun 2014

References

  • Govindarajan B, Menon BB, Spurr-Michaud S, et al. A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One. 2012;7:e32418
  • Liesegang TJ. Bacterial keratitis. In Kaufman HE, Baron BA, McDonald MB (eds.), The Cornea, 2nd ed. Boston: Butterworth-Heineman; 1998:159–218
  • Wong VW, Lai TY, Chi SC, Lam DS. Pediatric ocular surface infections: a 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment. Cornea. 2011;30:995–1002
  • Jeng BH, Gritz DC, Kumar AB, et al. Epidemiology of ulcerative keratitis in Northern California. Arch Ophthalmol. 2010;128:1022–1028
  • Kerr N, Stern GA. Bacterial keratitis associated with vernal keratoconjunctivitis. Cornea. 1992;11:355–359
  • Palmer ML, Hyndiuk RA. Contact lens-related infectious keratitis. Int Ophthalmol Clin. 1993;33:23–49
  • Sowka JW, Gurwood AS, Kabat AG. Handbook of Ocular Disease Management Web Site: Bacterial Keratitis. New York, NY: Jobson; 2001
  • Callegan MC, Engel LS, Hill JM, O’Callaghan RJ. Corneal virulence of Staphylococcus aureus: roles of α-toxin and protein A in pathogenesis. Infect Immun. 1994;62:2478–2482
  • O’Callaghan RJ, Callegan MC, Moreau JM, et al. Specific roles of α-toxin and β-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65:1571–1578
  • Projan S, Novick R. The molecular basis of pathogenicity. In Crossley K, Archer G (eds.), The Staphylococci in Human Disease. New York: Churchill Livingston; 1999:55–82
  • Chusid MJ, Davis SD. Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense. Infect Immun. 1979;24:948–952
  • Girgis DO, Sloop GD, Reed JM, O’Callaghan RJ. Effects of toxin production in a murine model of Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci. 2005;46:2064–2070
  • O’Callaghan RJ, Callegan MC, Moreau JM, et al. Specific roles of α-toxin and β-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65:1571–1578
  • Moreau JM, Sloop GD, Engel LS, et al. Histopathological studies of staphylococcal α-toxin: effects on rabbit corneas. Curr Eye Res. 1997;16:1221–1228
  • Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microb Rev. 2000;13:16–34
  • Bownik A, Siwicki AK. Effects of staphylococcal hemolysins on the immune system. Centrl Eur J Immunol. 2008;33:87–90
  • Powers ME, Kim HK, Wang Y, Bubeck WJ. ADAM10 mediates vascular injury induced by Staphylococcus aureus alpha hemolysin. J Infect Dis. 2012;206:352–356
  • Berube BJ, Wardenburg JB. Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins. 2013;5:1140–1166
  • McCormick CC, Caballero AR, Balzli CL, et al. Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus. Invest Ophthalmol Vis Sci. 2009;50:2848–2854
  • Dajcs JJ, Austin MS, Sloop GD, et al. Corneal pathogenesis of Staphylococcus aureus strain Newman. Invest Ophthalmol Vis Sci. 2002;43:1109–1115
  • Dajcs JJ, Thibodeaux BA, Girgis DO, O’Callaghan, RJ. Corneal virulence of Staphylococcus aureus in an experimental model of keratitis. DNA Cell Biol. 2002;21:375–382
  • Hume EB, Dajcs JJ, Moreau JM, O’Callaghan RJ. Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Infect Immun. 2000;68:6052–6055
  • Weeks AC, Balzli CL, Caballero AR, et al. Identification and potency of cyclodextrin-lipid inhibitors of Staphylococcus aureus α-toxin. Curr Eye Res. 2012;37:87–93
  • Foletti D, Strop P, Shaughnessy L, et al. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. J Mol Biol. 2013;425:1641–1654
  • Hobden JA, Reidy JJ, O’Callaghan RJ, et al. Treatment of experimental Pseudomonas keratitis using collagen shields containing tobramycin. Arch Ophthalmol. 1988;106:1605–1607
  • Wensheng C, Zhiyuan L, Jiaoyue H, et al. Corneal alternations induced by topical application of benzalkonium chloride in rabbit. PLOS One. 2011;6:1–8
  • Romanowski EG, Mah FS, Kowalski RP, et al. Benzalkonium chloride enhances the antibacterial efficacy of gatifloxacin in an experimental rabbit model of intrastromal keratitis. J Ocular Pharm Therapeutics. 2008;24:380–384

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.